Benjamin Bearnot1, Julian A Mitton. 1. Division of General Internal Medicine, Massachusetts General Hospital, Boston, Massachusetts (BB, JAM); Harvard Medical School, Boston, MA (BB, JAM); Mongan Institute, Massachusetts General Hospital, Boston, MA (BB).
Abstract
OBJECTIVES: Serious infectious complications of opioid use disorder (OUD), and specifically endocarditis, are becoming more common in the US. Individuals with OUD-associated endocarditis require long periods of complex medical care, often face recurrent addiction- and infection-related complications, and have dismal clinical outcomes. The objective of this study was to perform journey mapping analysis to capture common trajectories and patterns of care for people with OUD-associated endocarditis. METHODS: This was an analysis of qualitative semi-structured interviews of individuals who received care for OUD-associated endocarditis. Interviews were conducted among individuals receiving care at a single academic healthcare system in Boston, Massachusetts. Ten participants meeting DSM-5 criteria for at least mild OUD and a culture-positive diagnosis of endocarditis who had previously completed care for OUD-associated endocarditis were recruited from inpatient and ambulatory settings. Details of participant's care episodes were extracted and visualized in an iterative journey mapping process. A grounded theory approach was then used to identify shared themes and care patterns among participants' journey maps. RESULTS: Common patterns of care included early addiction treatment and intensive outpatient care preceding periods without rehospitalization, while leaving outpatient care and return to drug use often directly preceded rehospitalization. Participants frequently left care by choice and proactively reengaged with care. CONCLUSIONS: Journey mapping is a novel, patient-centered approach to capturing the care experiences and trajectories of a patient population experiencing significant stigma, who engage with the healthcare system in unexpected and fragmented ways. For individuals with OUD-associated endocarditis, we identified critical moments to support and engage patients to prevent return to drug use and rehospitalization.
OBJECTIVES: Serious infectious complications of opioid use disorder (OUD), and specifically endocarditis, are becoming more common in the US. Individuals with OUD-associated endocarditis require long periods of complex medical care, often face recurrent addiction- and infection-related complications, and have dismal clinical outcomes. The objective of this study was to perform journey mapping analysis to capture common trajectories and patterns of care for people with OUD-associated endocarditis. METHODS: This was an analysis of qualitative semi-structured interviews of individuals who received care for OUD-associated endocarditis. Interviews were conducted among individuals receiving care at a single academic healthcare system in Boston, Massachusetts. Ten participants meeting DSM-5 criteria for at least mild OUD and a culture-positive diagnosis of endocarditis who had previously completed care for OUD-associated endocarditis were recruited from inpatient and ambulatory settings. Details of participant's care episodes were extracted and visualized in an iterative journey mapping process. A grounded theory approach was then used to identify shared themes and care patterns among participants' journey maps. RESULTS: Common patterns of care included early addiction treatment and intensive outpatient care preceding periods without rehospitalization, while leaving outpatient care and return to drug use often directly preceded rehospitalization. Participants frequently left care by choice and proactively reengaged with care. CONCLUSIONS: Journey mapping is a novel, patient-centered approach to capturing the care experiences and trajectories of a patient population experiencing significant stigma, who engage with the healthcare system in unexpected and fragmented ways. For individuals with OUD-associated endocarditis, we identified critical moments to support and engage patients to prevent return to drug use and rehospitalization.
Authors: Sarah E Wakeman; Joshua P Metlay; Yuchiao Chang; Grace E Herman; Nancy A Rigotti Journal: J Gen Intern Med Date: 2017-05-19 Impact factor: 5.128
Authors: Leonieke C van Boekel; Evelien P M Brouwers; Jaap van Weeghel; Henk F L Garretsen Journal: Drug Alcohol Depend Date: 2013-03-13 Impact factor: 4.492
Authors: Elana S Rosenthal; Adolf W Karchmer; Jesse Theisen-Toupal; Roger Araujo Castillo; Chris F Rowley Journal: Am J Med Date: 2015-11-18 Impact factor: 4.965
Authors: Alysse G Wurcel; Jordan E Anderson; Kenneth K H Chui; Sally Skinner; Tamsin A Knox; David R Snydman; Thomas J Stopka Journal: Open Forum Infect Dis Date: 2016-07-26 Impact factor: 3.835
Authors: Yoelkys Morales; Emma Smyth; Julia Zubiago; Benjamin Bearnot; Alysse G Wurcel Journal: Open Forum Infect Dis Date: 2022-10-19 Impact factor: 4.423
Authors: Sarah E Ray; Vanessa Boudewyns; Christine Davis; Janice P Tzeng; Ila Srivastava; Oluwamurewa Oguntimein; Denise S Conti; Karen B Feibus Journal: Int J Chron Obstruct Pulmon Dis Date: 2022-08-06